FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948416105> ?p ?o ?g. }

• W2948416105 endingPage "1340" @default.
• W2948416105 startingPage "1331" @default.
• W2948416105 abstract "Single domain antibodies that combine antigen specificity with high tissue penetration are an attractive alternative to conventional antibodies. However, rapid clearance from the bloodstream owing to their small size can be a limitation of therapeutic single domain antibodies. Here, we describe and evaluate the conjugation of a single domain i-body, AD-114, which targets CXCR4, to a panel of half-life extension technologies including a human serum albumin-binding peptide, linear and branched PEG, and PASylation (PA600). The conjugates were assessed in murine, rat and cynomolgus monkey pharmacokinetic studies and showed that the branched PEG was most effective at extending circulating half-life in mice; however, manufacturing limitations of PEGylated test material precluded scale-up and assessment in larger animals. PA600, by comparison, was amenable to scale-up and afforded considerable half-life improvements in mice, rats and cynomolgus monkeys. In mice, the circulating half-life of AD-114 was extended from 0.18 h to 7.77 h following conjugation to PA600, and in cynomolgus monkeys, the circulating half-life of AD-114-PA600 was 24.27 h. AD-114-PA600 was well tolerated in cynomolgus monkeys at dose rates up to 100 mg/kg with no mortalities or drug-related clinical signs." @default.
• W2948416105 created "2019-06-14" @default.
• W2948416105 creator A5018442681 @default.
• W2948416105 creator A5034805810 @default.
• W2948416105 creator A5043515383 @default.
• W2948416105 creator A5049417070 @default.
• W2948416105 creator A5050881692 @default.
• W2948416105 creator A5063732261 @default.
• W2948416105 creator A5072379140 @default.
• W2948416105 creator A5074759851 @default.
• W2948416105 creator A5076163764 @default.
• W2948416105 creator A5080958173 @default.
• W2948416105 creator A5087078878 @default.
• W2948416105 creator A5088928746 @default.
• W2948416105 date "2019-08-23" @default.
• W2948416105 modified "2023-09-26" @default.
• W2948416105 title "Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4" @default.
• W2948416105 cites W1848085765 @default.
• W2948416105 cites W1884460322 @default.
• W2948416105 cites W1971972971 @default.
• W2948416105 cites W1989035987 @default.
• W2948416105 cites W2001239531 @default.
• W2948416105 cites W2027268124 @default.
• W2948416105 cites W2027756860 @default.
• W2948416105 cites W2031804837 @default.
• W2948416105 cites W2035776098 @default.
• W2948416105 cites W2046017891 @default.
• W2948416105 cites W2054597378 @default.
• W2948416105 cites W2076709027 @default.
• W2948416105 cites W2080335269 @default.
• W2948416105 cites W2083916238 @default.
• W2948416105 cites W2085768244 @default.
• W2948416105 cites W2146029618 @default.
• W2948416105 cites W2155664228 @default.
• W2948416105 cites W2168848424 @default.
• W2948416105 cites W2179446546 @default.
• W2948416105 cites W2291150896 @default.
• W2948416105 cites W2302120143 @default.
• W2948416105 cites W2316569370 @default.
• W2948416105 cites W2330144095 @default.
• W2948416105 cites W2618875195 @default.
• W2948416105 cites W2727454415 @default.
• W2948416105 cites W2769445535 @default.
• W2948416105 cites W2805762351 @default.
• W2948416105 cites W2915483287 @default.
• W2948416105 doi "https://doi.org/10.1080/19420862.2019.1626652" @default.
• W2948416105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6748587" @default.
• W2948416105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31156041" @default.
• W2948416105 hasPublicationYear "2019" @default.
• W2948416105 type Work @default.
• W2948416105 sameAs 2948416105 @default.
• W2948416105 citedByCount "14" @default.
• W2948416105 countsByYear W29484161052019 @default.
• W2948416105 countsByYear W29484161052020 @default.
• W2948416105 countsByYear W29484161052021 @default.
• W2948416105 countsByYear W29484161052022 @default.
• W2948416105 countsByYear W29484161052023 @default.
• W2948416105 crossrefType "journal-article" @default.
• W2948416105 hasAuthorship W2948416105A5018442681 @default.
• W2948416105 hasAuthorship W2948416105A5034805810 @default.
• W2948416105 hasAuthorship W2948416105A5043515383 @default.
• W2948416105 hasAuthorship W2948416105A5049417070 @default.
• W2948416105 hasAuthorship W2948416105A5050881692 @default.
• W2948416105 hasAuthorship W2948416105A5063732261 @default.
• W2948416105 hasAuthorship W2948416105A5072379140 @default.
• W2948416105 hasAuthorship W2948416105A5074759851 @default.
• W2948416105 hasAuthorship W2948416105A5076163764 @default.
• W2948416105 hasAuthorship W2948416105A5080958173 @default.
• W2948416105 hasAuthorship W2948416105A5087078878 @default.
• W2948416105 hasAuthorship W2948416105A5088928746 @default.
• W2948416105 hasBestOaLocation W29484161051 @default.
• W2948416105 hasConcept C112705442 @default.
• W2948416105 hasConcept C159654299 @default.
• W2948416105 hasConcept C203014093 @default.
• W2948416105 hasConcept C2778597219 @default.
• W2948416105 hasConcept C2780649865 @default.
• W2948416105 hasConcept C2780898057 @default.
• W2948416105 hasConcept C542903549 @default.
• W2948416105 hasConcept C55493867 @default.
• W2948416105 hasConcept C71924100 @default.
• W2948416105 hasConcept C86803240 @default.
• W2948416105 hasConcept C98274493 @default.
• W2948416105 hasConceptScore W2948416105C112705442 @default.
• W2948416105 hasConceptScore W2948416105C159654299 @default.
• W2948416105 hasConceptScore W2948416105C203014093 @default.
• W2948416105 hasConceptScore W2948416105C2778597219 @default.
• W2948416105 hasConceptScore W2948416105C2780649865 @default.
• W2948416105 hasConceptScore W2948416105C2780898057 @default.
• W2948416105 hasConceptScore W2948416105C542903549 @default.
• W2948416105 hasConceptScore W2948416105C55493867 @default.
• W2948416105 hasConceptScore W2948416105C71924100 @default.
• W2948416105 hasConceptScore W2948416105C86803240 @default.
• W2948416105 hasConceptScore W2948416105C98274493 @default.
• W2948416105 hasIssue "7" @default.
• W2948416105 hasLocation W29484161051 @default.
• W2948416105 hasLocation W29484161052 @default.
• W2948416105 hasLocation W29484161053 @default.
• W2948416105 hasLocation W29484161054 @default.

• next